A novel super-potent neurokinin A receptor antagonist containing dehydroalanine

被引:10
|
作者
Lombardi, A
D'Agostino, B
Nastri, F
D'Andrea, LD
Filippelli, A
Falciani, M
Rossi, F
Pavone, V
机构
[1] Univ Naples Federico II, CNR, Ctr Interuniv Ric Peptidi Bioattivi, I-80134 Naples, Italy
[2] Univ Naples Federico II, CNR, Ctr Studio Biocristallog, I-80134 Naples, Italy
[3] Univ Naples 2, Ist Farmacol & Tossicol, I-80100 Naples, Italy
关键词
D O I
10.1016/S0960-894X(98)00178-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report here the synthesis and preliminary pharmacological characterization of a novel Neurokinin A receptor antagonist. This molecule contains a dehydroalanine residue. It displays a high conformational rigidity and possesses very high activity. Its pharmacological properties as a neurokinin A receptor antagonist were assessed in in vitro experiments on rat vas deferens and were compared to those of Neuronorm and MEN10627. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1153 / 1156
页数:4
相关论文
共 50 条
  • [31] CHARACTERIZATION OF A NOVEL AND POTENT 5-HYDROXYTRYPTAMINE1A RECEPTOR ANTAGONIST
    LIAU, LM
    SLEIGHT, AJ
    PITHA, J
    PEROUTKA, SJ
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (03) : 555 - 559
  • [32] Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist
    Fuhrmann, U
    Hess-Stumpp, H
    Cleve, A
    Neef, G
    Schwede, W
    Hoffmann, J
    Fritzemeier, KH
    Chwalisz, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) : 5010 - 5016
  • [33] Click chemistry on solid phase:: Parallel synthesis of N-benzyltriazole carboxamides as super-potent G-protein coupled receptor ligands
    Loaiza, PR
    Löber, S
    Hübner, H
    Gmeiner, P
    JOURNAL OF COMBINATORIAL CHEMISTRY, 2006, 8 (02): : 252 - 261
  • [34] Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists
    Chambers, JJ
    Kurrasch-Orbaugh, DM
    Parker, MA
    Nichols, DE
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (06) : 1003 - 1010
  • [35] Assessment of hydro-saline retention in bullous pemphigoid patients treated with super-potent topical corticosteroids
    Hebert, V.
    Duvert-Lehembre, S.
    Deschamps-Huvier, A.
    Vannier, M.
    Thill, C.
    Joly, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (01): : 35 - 38
  • [36] Sch 217048: A novel cyclodepsipeptide with neurokinin antagonist activity
    Hegde, VR
    Puar, MS
    Chan, TM
    Dai, P
    Das, PR
    Patel, M
    JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (25): : 9584 - 9586
  • [37] Potent nonpeptide vitronectin receptor antagonist
    Terrett, N
    DRUG DISCOVERY TODAY, 1997, 2 (11) : 501 - 501
  • [38] BMS-189453, a novel retinoid receptor antagonist, is a potent testicular toxin
    Schulze, GE
    Clay, RJ
    Mezza, LE
    Bregman, CL
    Buroker, RA
    Frantz, JD
    TOXICOLOGICAL SCIENCES, 2001, 59 (02) : 297 - 308
  • [39] Effects of neurokinin B and neurokinin 3 receptor antagonist on pulsatile LH secretion in female rats
    Noritake, K.
    Sanbuissho, A.
    Uenoyama, Y.
    Tsukamura, H.
    Maeda, K.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2007, 79 (05) : 425 - 425
  • [40] Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist
    More, JCA
    Nistico, R
    Dolman, NP
    Clarke, VRJ
    Alt, AJ
    Ogden, AM
    Buelens, FP
    Troop, HM
    Kelland, EE
    Pilato, F
    Bleakman, D
    Bortolotto, ZA
    Collingridge, GL
    Jane, DE
    NEUROPHARMACOLOGY, 2004, 47 (01) : 46 - 64